RS Research vs Barinthus Biotherapeutics
RS Research
Clinically-validated biotech company for targeted therapies, disrupting the efficacy-toxicity trade-off
30 employees · est. 2015 · Istanbul, Turkey
Barinthus Biotherapeutics
Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates
34 employees · est. 2016 · Oxford, United Kingdom
RS Research is the older company (2015 vs 2016).
Side-by-Side Comparison
| Metric | RS Research | Barinthus Biotherapeutics |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2016 |
| Headquarters | ||
| Headquarters | Istanbul, Turkey | Oxford, United Kingdom |
| Employees | ||
| Employees | 30 | 34 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health and Wellness, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series A | Acquired |
| Total Funding | ||
| Total Funding | $14.00M | $146.66M |
| Funding Rounds | ||
| Funding Rounds | 4 | 7 |
| Services | ||
| Services | Development of targeted oncology therapies, Sagitta® drug delivery platform, Clinical trials for cancer treatment | Development of antigen-specific immunotherapies, Phase 1b/2 clinical trials, Pipeline management for autoimmune diseases and chronic viral infections, Biopharmaceutical research and development |
| Target Customers | ||
| Target Customers | Oncologists, Pharmaceutical companies, Research institutions, Healthcare providers | Patients with autoimmune and inflammatory conditions, Patients with chronic viral infections, Healthcare providers, Oncologists |
| Taxonomy | ||
| Taxonomy | Clinical-stage BiotechnologySmart NanomedicinesTargeted ChemotherapyDrug Delivery PlatformSagitta®Cancer Therapy +9 | T-cell ImmunotherapeuticsChronic Infectious DiseasesAutoimmunityCancer TreatmentChAdOx TechnologyMVA Boost Vector +9 |
| Website | ||
| Website | rsresearch.net | barinthusbio.com |
About RS Research
RS Research is a clinical-stage biotechnology start-up headquartered in Turkey that is at the forefront of developing smart nanomedicines for targeted chemotherapy. Established in 2015, the company leverages its innovative drug delivery platform, Sagitta®, aiming to provide a “Cure With a Smile” thr...
About Barinthus Biotherapeutics
Barinthus Biotherapeutics, founded in 2016, is a United Kingdom-based clinical-stage biopharmaceutical company that is innovating in the realms of Biotechnology, Health and Wellness, and Pharmaceutical industries. The company specializes in developing novel T-cell immunotherapeutic candidates aimed...
Also comparing in this category
Comparing more than these two?
Get RS Research, Barinthus Biotherapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does RS Research compare?
A PDF of RS Research and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare RS Research with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at RS Research on 4 Mar 2026, and Barinthus Biotherapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.